Tudor Investment Corp’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-133,436
Closed -$2.85M 2884
2021
Q4
$2.85M Buy
133,436
+95,447
+251% +$1.88M 0.05% 473
2021
Q3
$702K Buy
37,989
+17,269
+83% +$348K 0.01% 1419
2021
Q2
$444K Buy
20,720
+10,651
+106% +$217K 0.01% 1214
2021
Q1
$194K Buy
+10,069
New +$177K ﹤0.01% 1439

Other funds holding OCDX

Tudor Investment Corp's OCDX Position: Q1 2022 in Review

Tudor Investment Corp sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 133,436 shares — an estimated $2.85M sold.

Tudor Investment Corp first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $2.85M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Tudor Investment Corp reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 133,436 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $2.85M.
  • Tudor Investment Corp first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Tudor Investment Corp's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.85M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.